Search - tctmd.com

Displaying 481 - 500 of 1039

Sort: Relevancy | Date

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

Presentation TCT 2015

TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics The CHAMPION PHOENIX Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Gregg W. Stone

October 13, 2015

Presentation TCT 2015

Keynote Lecture 1: A Revitalization Plan for the FDA-CDRH Emphasis on Policy Changes, Innovation, and Technology

Presenter: Gregg W. Stone, Bram D. Zuckerman, Jeffrey Shuren

October 13, 2015

Presentation TCT 2015

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

Presenter: Gregg W. Stone, Bram D. Zuckerman

October 13, 2015

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

Presentation TCT 2015

VALcare: Device Description, Experiences, and Future Directions

Presenter: David H. Adams, Gregg W. Stone, David Meerkin

October 12, 2015

Presentation TCT 2015

MValve Docking System: Novel Design Features and Clinical Updates

Presenter: David H. Adams, Gregg W. Stone, Maurice Buchbinder

October 12, 2015

Presentation TCT 2015

Valtech Cardiovalve: Novel Design Features and Clinical Updates

Presenter: David H. Adams, Gregg W. Stone, Francesco Maisano

October 12, 2015

Presentation TCT 2015

A Novel Transcatheter Mitral Valved Stent for Secondary MR

Presenter: David H. Adams, Gregg W. Stone, Jose Luis Navia

October 12, 2015

Presentation TCT 2015

SinoMed AccuFit: Novel Design Features and Clinical Updates

Presenter: David H. Adams, Gregg W. Stone, Patrick W. Serruys

October 12, 2015

Presentation TCT 2015

Tiara: Novel Design Features and Clinical Updates

Presenter: David H. Adams, Gregg W. Stone, Anson Cheung

October 12, 2015

Presentation TCT 2015

Fortis: Novel Design Features and Clinical Updates

Presenter: David H. Adams, Gregg W. Stone, Vinod H. Thourani

October 12, 2015

Presentation TCT 2015

Tendyne: Novel Design Features and Clinical Updates

Presenter: David H. Adams, Gregg W. Stone, Neil E. Moat

October 12, 2015

Presentation TCT 2015

CardiAQ: Novel Design Features and Clinical Updates

Presenter: David H. Adams, Gregg W. Stone, Gian Paolo Ussia

October 12, 2015

Presentation TCT 2015

HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Clinical/Trialist Perspective

Presenter: Bernard J. Gersh, William S. Weintraub, Gregg W. Stone

October 12, 2015

Presentation TCT 2015

Latest Concepts in Focal Vulnerable Plaque Stabilization: Scaffold Treatment

Presenter: Gregg W. Stone, Renu Virmani, Patrick W. Serruys

October 12, 2015

Presentation TCT 2015

Will PCSK9 Inhibitors Transform the Natural History of Atherosclerosis?

Presenter: Gregg W. Stone, Renu Virmani, Philippe Gabriel Steg

October 12, 2015

Presentation TCT 2015

The Intersection of Plaque Morphology and Endothelial Shear Stress: New Insights From PROSPECT

Presenter: Gregg W. Stone, Renu Virmani, Peter H. Stone

October 12, 2015

Presentation TCT 2015

Integrative Imaging of Atherosclerotic Structure and Biology

Presenter: Gregg W. Stone, Renu Virmani, Ahmed A. Tawakol

October 12, 2015

Presentation TCT 2015

Whats New in Coronary Vulnerable Plaque Detection: Noninvasive Imaging

Presenter: Gregg W. Stone, Renu Virmani, James K. Min

October 12, 2015

Advertisement

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics The CHAMPION PHOENIX Trial

Keynote Lecture 1: A Revitalization Plan for the FDA-CDRH Emphasis on Policy Changes, Innovation, and Technology

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

VALcare: Device Description, Experiences, and Future Directions

MValve Docking System: Novel Design Features and Clinical Updates

Valtech Cardiovalve: Novel Design Features and Clinical Updates

A Novel Transcatheter Mitral Valved Stent for Secondary MR

SinoMed AccuFit: Novel Design Features and Clinical Updates

Tiara: Novel Design Features and Clinical Updates

Fortis: Novel Design Features and Clinical Updates

Tendyne: Novel Design Features and Clinical Updates

CardiAQ: Novel Design Features and Clinical Updates

HOT TOPIC 2: Balancing Safety and Efficacy Endpoints How Do Net Clinical Benefit and Quality of Life Fit Into the Equation? FOCUS on DAPT, PEGASUS, and MATRIX: Clinical/Trialist Perspective

Latest Concepts in Focal Vulnerable Plaque Stabilization: Scaffold Treatment

Will PCSK9 Inhibitors Transform the Natural History of Atherosclerosis?

The Intersection of Plaque Morphology and Endothelial Shear Stress: New Insights From PROSPECT

Integrative Imaging of Atherosclerotic Structure and Biology

Whats New in Coronary Vulnerable Plaque Detection: Noninvasive Imaging

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content